Upcoming Catalyst Makes Iveric Bio a Must Watch!
Iveric Bio, Inc. ( NASDAQ: ISEE) is a clinical-stage biopharmaceutical company developing transformative therapies for retinal diseases with significant unmet needs. The Company is developing a diverse portfolio of therapeutic candidates at various stages of development. The Company’s lead product candidate is Zimura (avacincaptad pegol),...
